Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.4783
-0.0346 (-6.75%)
Mar 31, 2025, 2:25 PM EDT - Market open
IPSC's stock price has decreased by -87.99% in the past year and price targets may not have had time to catch up.
Century Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$4.67
Upside
+876.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +1,363.52% | Mar 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +945.37% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +318.15% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +945.37% | Jan 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +736.30% | Dec 30, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +2,199.81% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +945.37% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,781.66% | Aug 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +2,408.89% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,199.81% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +2,199.81% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +1,781.66% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +2,617.96% | Mar 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +4,917.77% | Mar 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.